SCHEMBL8708200

SCHEMBL8708200

CC(C)(C)OC(=O)n1ncc2cccc([N+](=O)[O-])c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
MET P08581 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TDP1 Q9NUW8 3/20 0.36
NOS1 P29475 2/20 0.36
NOS2 P35228 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
THRB P10828 1/20 0.36
APEX1 P27695 1/20 0.36
NOS3 P29474 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30292229 0.80 ELANE (0.39) MAPTLMNAELANELCKEGFR
SCHEMBL29510797 0.80 CREBBP (0.44) ALDH1A1METMAPTLMNANPSR1
SCHEMBL2481191 0.80 CREBBP (0.44) ALDH1A1METMAPTLMNANPSR1
SCHEMBL25287629 0.79 ELANE (0.41) MEN1KMT2ACYP1A2CYP2C19HTT
SCHEMBL30556604 0.79 ROCK2 (0.42) LMNAMEN1KMT2AELANEEGFR
SCHEMBL8708836 0.79 ELANE (0.38) ELANEEGFRITK
SCHEMBL30438541 0.79 CYP11B1 (0.43) THRBELANEEGFRITK
SCHEMBL21054987 0.77 ACLY (0.44) ALDH1A1METMAPTLMNANPSR1
SCHEMBL15502414 0.76 POLB (0.41) ALDH1A1METMAPTLMNANPSR1
SCHEMBL15719632 0.76 TDP1 (0.36) ALDH1A1METMAPTLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5795887-A Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds GLAXO WELLCOME INC. (US) 1998-08-18 US disclosed
EP-0755394-A1 A METHOD OF INDUCING CHOLECYSTOKININ AGONIST ACTIVITY USING 1,4-BENZODIAZEPINE COMPOUNDS GLAXO WELLCOME INC. (US) 1997-01-29 EP disclosed
WO-1995028399-A1 A METHOD OF INDUCING CHOLECYSTOKININ AGONIST ACTIVITY USING 1,4-BENZODIAZEPINE COMPOUNDS GLAXO WELLCOME INC. (US) 1995-10-26 WO disclosed